linkedin

Resource Library

Webinars

Key Considerations When Selecting a mRNA CDMO Partner

In case you missed our webinar in collaboration with Pharmaceutical Technology, check out the full session where our experts – Pierre Catignol and Eunseo Lee – share their insights on challenges in the field of mRNA-based therapeutics, strategies to design mRNA-LNP process, and the importance of end-to-end services. 

In case you missed our webinar “Key Considerations When Selecting a mRNA CDMO Partner,” check out the full session on our website. Our experts – Pierre Catignol and Eunseo Lee – shared their insights on challenges in the field of mRNA-based therapeutics, strategies to design mRNA-LNP process, and the importance of end-to-end services.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION